Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Financing Activities (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Cash from Financing Activities for 5 consecutive years, with $6.1 million as the latest value for Q4 2018.

  • Quarterly Cash from Financing Activities rose 3055.83% to $6.1 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $12.5 million through Dec 2018, up 43.59% year-over-year, with the annual reading at $25.6 million for FY2025, 26.73% down from the prior year.
  • Cash from Financing Activities hit $6.1 million in Q4 2018 for Armata Pharmaceuticals, up from -$44000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $12.4 million in Q1 2015 to a low of -$611000.0 in Q3 2017.
  • Historically, Cash from Financing Activities has averaged $2.9 million across 4 years, with a median of -$1000.0 in 2015.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 3494.12% in 2017 and later soared 3324.39% in 2018.
  • Year by year, Cash from Financing Activities stood at -$1000.0 in 2015, then surged by 325600.0% to $3.3 million in 2016, then plummeted by 106.33% to -$206000.0 in 2017, then surged by 3055.83% to $6.1 million in 2018.
  • Business Quant data shows Cash from Financing Activities for ARMP at $6.1 million in Q4 2018, -$44000.0 in Q3 2018, and -$204000.0 in Q2 2018.